Literature DB >> 20194015

Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003.

Ramandeep S Arora1, Robert D Alston, Tim O B Eden, Edward J Estlin, Anthony Moran, Marco Geraci, Jillian M Birch.   

Abstract

Reported increases in the incidence of CNS tumours in the developed world in the 1970s to 1990s have been a cause for concern and debate. It still remains to be adequately answered whether these increases are true or an artefact of changes in diagnostic and registration practices. Using high-quality national cancer registration data, we have analysed incidence trends for each major histological subgroup of CNS tumour (2000 World Health Organisation (WHO) classification) registered in those aged 0-84 years for the whole of England during the period 1979 through 2003. 134,509 primary CNS tumours of malignant, benign and uncertain behaviour located in the brain, meninges, spinal cord, cranial nerves, other parts of the central nervous system and in the pituitary and pineal glands were registered. In summary, we present the single largest nationwide study on the longitudinal incidence trends of CNS tumours. The increase in incidence observed in the 1970s and 1980s was mainly in the young and the elderly and has now plateaued and may even be decreasing. There is however variation in trends by histology. The incidence of some histological sub-groups has continued to increase until the most recent period of analysis. Much of the initial increase can be attributed to the emergence of much more widely available neuroimaging, while the most recent incidence changes for specific sub-groups of CNS tumours appear to be due to greater diagnostic specificity leading to a shift in registered categories. However, the trends for high-grade astrocytomas and other gliomas need further observation and investigation. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20194015     DOI: 10.1016/j.ejca.2010.02.007

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  19 in total

1.  Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France.

Authors:  Amélie Darlix; Sonia Zouaoui; Jean-Marc Virion; Valérie Rigau; Hélène Mathieu-Daudé; Marie Blonski; German Reyes-Botero; Faiza Bessaoud; Brigitte Trétarre; Fabienne Bauchet; Laurent Capelle; Michel Fabbro; Christine Kerr; Dominique Figarella-Branger; Hugues Duffau; Luc Taillandier; Luc Bauchet
Journal:  J Neurooncol       Date:  2014-08-24       Impact factor: 4.130

Review 2.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

3.  Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

Authors:  I Baldi; A Gruber; A Alioum; E Berteaud; P Lebailly; A Huchet; T Tourdias; G Kantor; J P Maire; A Vital; H Loiseau
Journal:  Neuro Oncol       Date:  2011-10-06       Impact factor: 12.300

4.  Epidemiology for primary brain tumors: a nationwide population-based study.

Authors:  Amélie Darlix; Sonia Zouaoui; Valérie Rigau; Faiza Bessaoud; Dominique Figarella-Branger; Hélène Mathieu-Daudé; Brigitte Trétarre; Fabienne Bauchet; Hugues Duffau; Luc Taillandier; Luc Bauchet
Journal:  J Neurooncol       Date:  2016-11-16       Impact factor: 4.130

5.  Is the incidence of brain tumors really increasing? A population-based analysis from a cancer registry.

Authors:  Adele Caldarella; Emanuele Crocetti; Eugenio Paci
Journal:  J Neurooncol       Date:  2011-02-17       Impact factor: 4.130

6.  Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.

Authors:  Rebecca L Achey; Vishesh Khanna; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2017-04-10       Impact factor: 4.130

7.  Trends in the Management Paradigms of Intracranial Meningioma.

Authors:  Zaid Aljuboori; Ahmad Alhourani; Shiao Woo; Eyas Hattab; Mehran Yusuf; Megan Nelson; Norberto Andaluz; Dale Ding; Jesse Savage; Brian Williams
Journal:  J Neurol Surg B Skull Base       Date:  2019-09-17

8.  Cancers of the brain and CNS: global patterns and trends in incidence.

Authors:  Adalberto Miranda-Filho; Marion Piñeros; Isabelle Soerjomataram; Isabelle Deltour; Freddie Bray
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

9.  An epidemiology report for primary central nervous system tumors in adolescents and young adults: a nationwide population-based study in France, 2008-2013.

Authors:  Sam Ng; Sonia Zouaoui; Faiza Bessaoud; Valérie Rigau; Alexandre Roux; Amélie Darlix; Fabienne Bauchet; Hélène Mathieu-Daudé; Brigitte Trétarre; Dominique Figarella-Branger; Johan Pallud; Didier Frappaz; Thomas Roujeau; Luc Bauchet
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

10.  Might changes in diagnostic practice explain increasing incidence of brain and central nervous system tumors? A population-based study in Wales (United Kingdom) and the United States.

Authors:  Michael Tin Chung Poon; Paul M Brennan; Kai Jin; Cathie L M Sudlow; Jonine D Figueroa
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.